抗Human SOST Biotinylated抗体(Anti-Human SOST Biotinylated antibody)

掲載日情報:2021/01/28 現在Webページ番号:195202

Human SOST Biotinylatedに対する抗体(Anti-Human SOST Biotinylated )です。
本製品は研究用です。研究用以外には使用できません。

価格

[在庫・価格 :2025年04月27日 00時00分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
納期 文献数
Anti-Human SOST Biotinylated MAb (Clone 220910)
10日程度 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 0
  • メーカーサイト
  • お問い合わせ
説明文
マッチドペア:Human SOST サンドイッチELISAの検出用抗体として利用可能,補足用抗体として#MAB1406-500,スタンダードとして#1406-ST-025を用いる。
別名:sclerostin
クローン:220910
Genbank No: 50964
Protein Accession No: Q9BQB4
法規制等
保存条件 -20℃ 法規備考
抗原種 免疫動物 Mouse クラス IgG 標識 Biotin
交差性 Human 適用 ELISA
クロナリティ Monoclonal フォーマット 性状 Protein A/G Affinity Purified 吸収処理
掲載カタログ

製品記事 Quantikine SOST ELISA Kit
関連記事 R&D Systems(R&Dシステムズ)社 ELISA用ペア抗体を使用したELISA 構築ガイド

[在庫・価格 :2025年04月27日 00時00分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Anti-Human SOST Biotinylated MAb (Clone 220910)

文献数: 0

説明文 マッチドペア:Human SOST サンドイッチELISAの検出用抗体として利用可能,補足用抗体として#MAB1406-500,スタンダードとして#1406-ST-025を用いる。
別名:sclerostin
クローン:220910
Genbank No: 50964
Protein Accession No: Q9BQB4
法規制等
保存条件 -20℃ 法規備考
抗原種 免疫動物 Mouse
交差性 Human 適用 ELISA
標識 Biotin 性状 Protein A/G Affinity Purified
吸収処理 クラス IgG
クロナリティ Monoclonal フォーマット
掲載カタログ

製品記事 Quantikine SOST ELISA Kit
関連記事 R&D Systems(R&Dシステムズ)社 ELISA用ペア抗体を使用したELISA 構築ガイド



目次に戻る

Product Details

Species ReactivityHuman
LabelBiotin
ImmunogenMouse myeloma cell line NS0-derived recombinant human SOST/SclerostinGln24-Tyr213Accession # Q9BQB4
SourceMonoclonal Mouse IgG1 Clone # 220910
PurificationProtein A or G purified from hybridoma culture supernatant
SpecificityDetects human SOST/Sclerostin in ELISAs. In sandwich immunoassays, 30% cross-reactivity with recombinant mouse SOST is observed and no cross-reactivity or interference with recombinant human BMP-2, -4, -5, -6, or -7 was observed.


目次に戻る

Applications and Data

 Recommended
Concentration
Sample
Human SOST Sandwich ImmunoassayReagent
ELISA Capture (Matched Antibody Pair)2-8 µg/mL Human SOST/Sclerostin Antibody (Catalog #MAB1406 )
ELISA Detection (Matched Antibody Pair)0.5-2.0 µg/mL Human SOST/Sclerostin Biotinylated Antibody (Catalog #BAM14061 )
ELISA Standard  Recombinant Human SOST/Sclerostin Protein (Catalog #1406-ST )
Please Note: Optimal dilutions should be determined by each laboratory for each application.General Protocolsare available in the Technical Information section on our website.Preparation and Storage
ReconstitutionReconstitute at 0.5 mg/mL in sterile PBS.Reconstitution Buffer Available
ShippingThe product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: SOST/SclerostinSOST, also known as sclerostin, is a member of the cerberus/DAN family, a group of secreted glycoproteins characterized by a cysteine-knot motif. Cerberus/DAN family members are putative BMP antagonists, and include Dan, Cerberus, Gremlin, PRDC, and Caronte. While the overall sequence identity between members of the family is low, they have conserved spacing of six cysteine residues. Cerberus and dan have an additional cysteine residue used for dimerization; however, SOST does not and is secreted as a monomer. SOST was originally identified as an important regulator of bone homesotasis. Positional cloning studies identified that mutations in the SOST gene can cause sclerosteosis and van Buchem disease, bone dysplasia disorders characterized by progressive skeletal overgrowth. Significant levels of SOST expression are detected in bone, cartilage, kidney, and liver. SOST is expressed by osteoclasts in developing bones of mouse embryos, including both intramembranously forming skull bones and endochondrally forming long bones. SOST plays a physiological role as a negative regulator of bone formation by repressing BMP-induced osteogenesis. SOST has been shown to have unique ligand specificity, binding BMP-5, -6, and -7 with high affinity and BMP-2 and -4 with low affinity. This seems to be the first example of a BMP antagonist being localized to osteoclasts, cells derived from the hematopoietic lineage, that function to degrade bone matrix. Recombinant human SOST preparations from R&D Systems bind BMP-5 and BMP-6 in a functional ELISA. Human and mouse SOST share 88% amino acid identity (1‑3).

目次に戻る

References

Kusu, N. et al. (2003) J. Biol. Chem. 278:24113.
Balemans, W. et al. (2001) Hum. Mol. Genet. 10:537.
Brunkow, M.E. et al. (2001) Am. J. Hum. Genet. 68:577.
Entrez Gene IDs:50964 (Human); 74499 (Mouse)
Alternate Names:sclerostin; SOST; VBCHsclerosteosis

目次に戻る

Related Research Areas

BMP Family
Osteocyte Markers
Osteogenesis Markers
TGF-beta Superfamily Modulators
Wnt Inhibitors


目次に戻る

Related Product & Information

BackgroundSOST/Sclerostin
background_contentBackground:
SOST/Sclerostin
SOST, also known as sclerostin, is a member of the cerberus/DAN family, a group of secreted glycoproteins characterized by a cysteine-knot motif. Cerberus/DAN family members are putative BMP antagonists, and include Dan, Cerberus, Gremlin, PRDC, and Caronte. While the overall sequence identity between members of the family is low, they have conserved spacing of six cysteine residues. Cerberus and dan have an additional cysteine residue used for dimerization; however, SOST does not and is secreted as a monomer. SOST was originally identified as an important regulator of bone homesotasis. Positional cloning studies identified that mutations in the SOST gene can cause sclerosteosis and van Buchem disease, bone dysplasia disorders characterized by progressive skeletal overgrowth. Significant levels of SOST expression are detected in bone, cartilage, kidney, and liver. SOST is expressed by osteoclasts in developing bones of mouse embryos, including both intramembranously forming skull bones and endochondrally forming long bones. SOST plays a physiological role as a negative regulator of bone formation by repressing BMP-induced osteogenesis. SOST has been shown to have unique ligand specificity, binding BMP-5, -6, and -7 with high affinity and BMP-2 and -4 with low affinity. This seems to be the first example of a BMP antagonist being localized to osteoclasts, cells derived from the hematopoietic lineage, that function to degrade bone matrix. Recombinant human SOST preparations from R&D Systems bind BMP-5 and BMP-6 in a functional ELISA. Human and mouse SOST share 88% amino acid identity (1‑3).


目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。